Last week, a group of Russian scientists published the results of two phase 1/2 vaccine trials for a new Covid-19 vaccine. Soon after the paper appeared, other scientists raised serious questions about the integrity of the data.
Last week, a group of Russian scientists published the results of two phase 1/2 vaccine trials for a new Covid-19 vaccine. Soon after the paper appeared, other scientists raised serious questions about the integrity of the data.